A Study to Assess Plasma Ammonia Time-Normalized Area Under the Curve and Rate of Ureagenesis in Healthy Adult Subjects
NCT04269122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2020-03-30
Summary
The objective of the study is to characterize 24-hour plasma ammonia levels, characterize urea production rates in healthy normal subjects.
Conditions
- Ornithine Transcarbamylase Deficiency
Interventions
- OTHER
-
No Intervention
No intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Ultragenyx Pharmaceutical
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-08-02
- Primary Completion
- 2020-02-20
- Completion
- 2020-02-20
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Roles of Uremic Toxins in Uremic Sacropenia
NCT03060590 ·Status: COMPLETED
-
Impact of Renal Replacement Therapy on Coagulation Profile of Patients with Acute Renal Failure
NCT03536195 ·Status: COMPLETED
-
Analysis of Clinical Outcomes in Patients Undergoing Acute Dialysis Therapy at Intensive Care Units
NCT01039753 ·Status: UNKNOWN
-
Open-Label Safety, Tolerability, PK Study of IV CXA-10 Emulsion in Subjects in Chronic Kidney Injury
NCT02248051 ·Status: COMPLETED ·Phase: PHASE1
-
Th1, Th2, Th17 Phenotype in Urea Cycle Disorders
NCT05706714 ·Status: COMPLETED
-
Pilot Study: Urea Cycle Disorders Practice Patterns and Outcomes Assessment
NCT02311283 ·Status: COMPLETED
-
Urinary NGAL Acute Kidney Injury After Stored Red Blood Cells Transfusion in Critically Ill Patients.
NCT03560921 ·Status: COMPLETED
-
Incidence of Acute Kidney Injury and Mortality in Critically Ill Patients: Urinary Chloride as a Prognostic Marker
NCT05542927 ·Status: UNKNOWN
-
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
NCT04986137 ·Status: UNKNOWN
-
Specimen Stability Study
NCT01846884 ·Status: COMPLETED
-
Different Ultrafiltration Rates and Intradialytic Hypotension.
NCT06695923 ·Status: COMPLETED
-
The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
NCT01275729 ·Status: COMPLETED ·Phase: NA
-
Observational Study of Blood Pressure Measurements and Continuous Dialysis
NCT01286506 ·Status: TERMINATED
-
Amino Acid Loss During Continuous Renal Replacement Therapy
NCT06659835 ·Status: RECRUITING
-
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
NCT01294228 ·Status: COMPLETED
-
ADMA Levels in End-Stage Renal Disease
NCT00350974 ·Status: COMPLETED
-
Spot Urine Oxalate to Creatinine Ratio and 24 Hours Urinary Oxalate
NCT04571359 ·Status: COMPLETED
-
L-Arginine, Symmetrical and Asymmetrical Dimethylarginine (SDMA/ADMA) in Acute Kidney Injury (AKI)
NCT01552525 ·Status: COMPLETED
-
Evaluation of the Accuracy and Usability of the ACR | U.S. Urine Analysis Test System in the Lay User Hands
NCT04626271 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Thyroid Function, Lipid Profile, and Uric Acid Levels in Hemodialysis Patients
NCT07157267 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Accuracy and Usability of the Minuteful - Kidney Urine Analysis Test System in the Lay User Hands
NCT05838872 ·Status: COMPLETED ·Phase: NA
-
24-hour Urinary Electrolyte Excretion in Chronic Kidney Disease
NCT05550467 ·Status: COMPLETED
-
Uric Acid and Menopausal Age in Acute Kidney Injury
NCT07044934 ·Status: COMPLETED
-
A Uremic Toxin Absorbent (AST-120) to Treat Hospital Acquired Acute Kidney Injury
NCT02687841 ·Status: UNKNOWN ·Phase: PHASE3
-
Role of Prohepcidin in Uremic Patients
NCT01735773 ·Status: COMPLETED